Inclusion of steps to enhance mucus clearance may provide benefit for symptomatic COVID patients by reducing total viral load, time to recovery, risk of complications and transmission risk

Author:

John Given,Charles Steele

Publisher

Peertechz Publications Private Limited

Subject

General Medicine

Reference28 articles.

1. 1. Tobaiqy M, Qashqary M, Al-Dahery S (2020) Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice. Link: https://bit.ly/3z2NCUH

2. 2. Pistelli R, Lange P, Miller DL (2021) Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. European Respiratory Society. Link: https://bit.ly/3ii4PmG

3. 3. Madhi SA, Al. E, for the NGS-SA Group Wits-VIDA COVID Group (2021) Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant: NEJM. Link: https://bit.ly/3hFkHAn

4. 4. Zanin M, Baviskar P, Webster R, Webby R (2021) The Interaction between Respiratory Pathogens and Mucus. Cell host & microbe. Link: https://bit.ly/3zduow3

5. 5. Roca O, Hernández G, Díaz-Lobato S (2021) Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Critical care (London, England). Link: https://bit.ly/36BF6A1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3